CAMBRIDGE, Mass., Aug. 4, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced today that it will participate in the 2011 Canaccord Genuity Growth Conference. Marc Beer, CEO of Aegerion, is scheduled to present on Thursday, August 11, 2011, at 9:00 a.m. ET.
